Helius Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Helius Medical Technologies
HSDT Stock  USD 0.49  0.03  6.52%   
Helius Medical financial statements provide useful quarterly and yearly information to potential Helius Medical Technologies investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Helius Medical financial statements helps investors assess Helius Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Helius Medical's valuation are summarized below:
Gross Profit
324 K
Market Capitalization
1.7 M
Enterprise Value Revenue
0.1433
Revenue
594 K
Earnings Share
(4.27)
There are currently one hundred twenty fundamental trends for Helius Medical Techn that can be evaluated and compared over time across competitors. All traders should confirm Helius Medical's regular fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 4.6 M in 2024. Enterprise Value is likely to gain to about (225.7 K) in 2024

Helius Medical Total Revenue

458,800

Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius Medical's main balance sheet or income statement drivers, such as Interest Expense of 244.2 K, Selling General Administrative of 9.6 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.21, Dividend Yield of 0.0 or PTB Ratio of 2.18. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.
  
Check out the analysis of Helius Medical Correlation against competitors.

Helius Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding577.5 K607.9 K5.9 M
Pretty Stable
Total Assets9.9 M7.7 M7.3 M
Slightly volatile
Total Current Liabilities1.8 M1.9 M4 M
Pretty Stable
Accounts Payable504.4 K531 K1.2 M
Pretty Stable
Cash7.6 M5.2 M5.6 M
Slightly volatile
Cash And Short Term Investments7.7 M5.2 M5.6 M
Slightly volatile
Common Stock Total Equity8559008.3 M
Pretty Stable
Liabilities And Stockholders Equity9.9 M7.7 M7.3 M
Slightly volatile
Other Current Assets777.2 K1 M630 K
Slightly volatile
Short and Long Term Debt11.6 M11 M6.3 M
Slightly volatile
Total Current Assets9.1 M7.4 M6.7 M
Slightly volatile
Short Term Debt85.5 K90 K2 M
Very volatile
Common Stock95010008.3 M
Pretty Stable
Other Current Liabilities994.6 K1 M3 M
Very volatile
Other Liabilities8.6 M8.2 M2.3 M
Slightly volatile
Long Term Debt1.8 M2 M1.7 M
Slightly volatile
Net Receivables401.2 K637 K272.2 K
Slightly volatile
Short Term Investments302.4 K340.2 K370.4 K
Slightly volatile
Non Current Liabilities Total2.6 M3.5 M2.1 M
Slightly volatile
Capital Surpluse149.6 M142.5 M60.5 M
Slightly volatile
Other Stockholder Equity91.3 M163 M61.8 M
Slightly volatile
Deferred Long Term Liabilities1.8 M2 M1.7 M
Slightly volatile
Property Plant And Equipment Net418.2 K230 K352.5 K
Slightly volatile
Current Deferred Revenue40.9 K43 K217.6 K
Slightly volatile
Other Assets15.4 K16.2 K37.3 K
Very volatile
Property Plant And Equipment Gross631.4 K589 K390.7 K
Slightly volatile
Property Plant Equipment612.1 K517.5 K378.6 K
Slightly volatile
Inventory531.9 K457 K437.9 K
Slightly volatile
Capital Stock950100020 K
Slightly volatile
Short and Long Term Debt Total54.1 K57 K445.7 K
Slightly volatile
Capital Lease Obligations54.1 K57 K445.7 K
Slightly volatile
Non Current Liabilities Other384.8 K226.8 K564.5 K
Slightly volatile
Intangible Assets22.8 K24 K457.8 K
Slightly volatile

Helius Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative9.6 M9.6 M8.2 M
Slightly volatile
Other Operating Expenses16.1 M13.1 M13.9 M
Slightly volatile
Research Development2.8 M2.9 M5.2 M
Very volatile
Total Operating Expenses15.9 M12.5 M13.8 M
Slightly volatile
Non Recurring1.8 M1.7 M1.1 M
Slightly volatile
Depreciation And Amortization214.2 K162 K138 K
Slightly volatile
Selling And Marketing Expenses619.5 K697 K758.9 K
Slightly volatile
Reconciled Depreciation217.6 K181 K114.8 K
Slightly volatile

Helius Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.6 M1.6 M3.9 M
Slightly volatile
Total Cash From Financing Activities1 M1.1 M9.3 M
Slightly volatile
End Period Cash Flow7 M5.2 M5.6 M
Slightly volatile
Sale Purchase Of Stock14.5 M11.1 M11.3 M
Pretty Stable
Net Borrowings2.4 M2.3 M1.5 M
Slightly volatile
Begin Period Cash Flow15.3 M14.5 M5.8 M
Slightly volatile
Depreciation153 K162 K112.5 K
Slightly volatile
Issuance Of Capital Stock269.8 K284 K26.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.217.5892268
Slightly volatile
Days Sales Outstanding379361215
Slightly volatile
Stock Based Compensation To Revenue4.512.52953.5488
Slightly volatile
Capex To Depreciation0.170.1796.6305
Slightly volatile
Inventory Turnover1.121.27571.2635
Slightly volatile
Days Of Inventory On Hand313286306
Slightly volatile
Payables Turnover1.151.09790.5888
Slightly volatile
Sales General And Administrative To Revenue28.8132.4135.2922
Slightly volatile
Research And Ddevelopement To Revenue4.344.568315.017
Slightly volatile
Capex To Revenue0.04280.0450.5895
Slightly volatile
Cash Per Share8.18.5246289
Very volatile
Days Payables Outstanding316332692
Slightly volatile
Income Quality0.661.17690.6864
Slightly volatile
Intangibles To Total Assets0.0030.00310.1367
Slightly volatile
Net Debt To EBITDA0.330.42330.3173
Slightly volatile
Current Ratio2.173.95852.0769
Slightly volatile
Receivables Turnover0.961.0111.8313
Very volatile
Graham Number33.8135.58542 K
Very volatile
Debt To Equity0.03640.01910.079
Slightly volatile
Capex Per Share0.04530.047713.6145
Slightly volatile
Average Receivables163.2 K183.6 K199.9 K
Slightly volatile
Revenue Per Share1.011.059431.5311
Slightly volatile
Interest Debt Per Share0.07030.074111
Very volatile
Debt To Assets0.00560.00590.0432
Slightly volatile
Operating Cycle467647465
Slightly volatile
Days Of Payables Outstanding316332692
Slightly volatile
Ebt Per Ebit1.050.71210.9828
Pretty Stable
Long Term Debt To Capitalization0.00750.00780.0517
Slightly volatile
Total Debt To Capitalization0.03390.01880.0716
Slightly volatile
Debt Equity Ratio0.03640.01910.079
Slightly volatile
Quick Ratio2.083.71532.0003
Slightly volatile
Cash Ratio1.742.75781.5406
Slightly volatile
Days Of Inventory Outstanding313286306
Slightly volatile
Days Of Sales Outstanding379361215
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.111.00281.0161
Slightly volatile
Fixed Asset Turnover2.942.81.2568
Slightly volatile
Debt Ratio0.00560.00590.0432
Slightly volatile
Price Sales Ratio7.217.5892268
Slightly volatile
Asset Turnover0.07870.08370.043
Slightly volatile
Gross Profit Margin0.090.09470.3856
Slightly volatile

Helius Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.6 M4.9 M13.4 M
Slightly volatile

Helius Fundamental Market Drivers

Cash And Short Term Investments5.2 M

Helius Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Helius Medical Financial Statements

Helius Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Helius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue43 K40.9 K
Total Revenue644 K458.8 K
Cost Of Revenue583 K612.1 K
Stock Based Compensation To Revenue 2.53  4.51 
Sales General And Administrative To Revenue 32.41  28.81 
Research And Ddevelopement To Revenue 4.57  4.34 
Capex To Revenue 0.05  0.04 
Revenue Per Share 1.06  1.01 
Ebit Per Revenue(19.30)(20.26)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY